Search Results - "Zumsteg, Zachary"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals by Tota, Joseph E, Best, Ana F, Zumsteg, Zachary S, Gillison, Maura L, Rosenberg, Philip S, Chaturvedi, Anil K

    Published in Journal of clinical oncology (20-06-2019)
    “…Human papillomavirus-positive oropharynx cancer incidence has increased rapidly in cohorts of US white men born during the 1930s to 1950s. It is unknown how…”
    Get full text
    Journal Article
  5. 5

    A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy by Zumsteg, Zachary S, Spratt, Daniel E, Pei, Isaac, Zhang, Zhigang, Yamada, Yoshiya, Kollmeier, Marisa, Zelefsky, Michael J

    Published in European urology (01-12-2013)
    “…Abstract Background The management of intermediate-risk prostate cancer (PCa) is controversial, in part due to the heterogeneous nature of patients falling…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer by Ho, Allen S, Kim, Sungjin, Tighiouart, Mourad, Gudino, Cynthia, Mita, Alain, Scher, Kevin S, Laury, Anna, Prasad, Ravi, Shiao, Stephen L, Van Eyk, Jennifer E, Zumsteg, Zachary S

    Published in Journal of clinical oncology (01-11-2017)
    “…Purpose Current staging systems for oral cavity cancers incorporate lymph node (LN) size and laterality, but place less weight on the total number of positive…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality by Spratt, Daniel E, Zhang, Chi, Zumsteg, Zachary S, Pei, Xin, Zhang, Zhigang, Zelefsky, Michael J

    Published in European urology (01-04-2013)
    “…Abstract Background In vitro data and early clinical results suggest that metformin has desirable antineoplastic effects and has a theoretical benefit on…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    A snapshot of the evolving epidemiology of oropharynx cancers by Chaturvedi, Anil K., Zumsteg, Zachary S.

    Published in Cancer (15-07-2018)
    “…The trajectory of the human papillomavirus–positive oropharyngeal cancer epidemic in the United States reveals that “what's past is prologue” (William…”
    Get full text
    Journal Article
  15. 15

    Treatment at high‐volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer by David, John M., Ho, Allen S., Luu, Michael, Yoshida, Emi J., Kim, Sungjin, Mita, Alain C., Scher, Kevin S., Shiao, Stephen L., Tighiouart, Mourad, Zumsteg, Zachary S.

    Published in Cancer (15-10-2017)
    “…BACKGROUND The treatment of head and neck cancers is complex and associated with significant morbidity, requiring multidisciplinary care and physician…”
    Get full text
    Journal Article
  16. 16

    Malpractice Trends Involving Active Surveillance Across Cancers by Chang, Samuel, Daskivich, Timothy J, Vasquez, Missael, Sacks, Wendy L, Zumsteg, Zachary S, Ho, Allen S

    Published in Annals of surgery (01-04-2024)
    “…To characterize malpractice trends related to active surveillance (AS) as a treatment strategy across cancers. Active surveillance is increasingly considered a…”
    Get full text
    Journal Article
  17. 17

    Comparison of high‐dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate‐risk prostate cancer by Spratt, Daniel E., Zumsteg, Zachary S., Ghadjar, Pirus, Kollmeier, Marisa A., Pei, Xin, Cohen, Gilad, Polkinghorn, William, Yamada, Yoshiya, Zelefsky, Michael J.

    Published in BJU international (01-09-2014)
    “…Objective To compare tumour control and toxicity outcomes with the use of high‐dose intensity‐modulated radiation therapy (IMRT) alone or brachytherapy…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Breast-Conserving Therapy Achieves Locoregional Outcomes Comparable to Mastectomy in Women with T1-2N0 Triple-Negative Breast Cancer by Zumsteg, Zachary S., Morrow, Monica, Arnold, Brittany, Zheng, Junting, Zhang, Zhigang, Robson, Mark, Traina, Tiffany, McCormick, Beryl, Powell, Simon, Ho, Alice Y.

    Published in Annals of surgical oncology (01-10-2013)
    “…Background Conflicting data exist regarding optimum local therapy for early-stage triple-negative breast cancer (TNBC). We examined outcomes according to local…”
    Get full text
    Journal Article
  20. 20